Direct Epidemio-Statistics — We deliver quantitative risk expertise for healthcare stakeholders
We help SMEs and innovative companies leverage precise data, model and score risks, anticipate adverse events, and create value-driven services.
RC-AVP /Addictions (psychiatrie)
RISK-SCO /Sécurité des Transports
CIR /Agrément 2022-2027
For care specialists — MD-PHD, nurses
Direct Epidemio-Statistics helps to screen patient health indicators in silico for early risk markers, anticipate multifactorial adverse events using scoring, prioritize risks, and explore target populations more easily and quickly. Our risk expertise provides the following benefits:
- Characterize patients more systematically
- Model multifactorial adverse events
- Compare subgroups more easily and quickly
- Improve patient survival
- Improve quality of life
- Reduce the number of serious adverse events (SAEs)
Extracts / client cases
For regulatory authorities
Direct Epidemio-Statistics' quantitative risk expertise helps you search for early risk markers, model multifactorial causes of serious adverse events, better understand the pathogenesis of these risks, prioritize risks, and perform surveillance using population databases (Real World Evidence). Benefits include:
- Simpler, systematic, large-scale surveillance
- Better understanding of the pathogenesis of adverse events
- Simpler, faster, and more accurate population comparisons
Extracts / client cases
<
1 / 3
>
CompanyOur contact detailsSales / HR contactOur web presenceLegal